Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1856 1
1895 1
1896 1
1897 1
1898 2
1902 1
1925 1
1928 1
1932 1
1935 1
1941 1
1945 1
1946 5
1947 12
1948 17
1949 15
1950 8
1951 18
1952 7
1953 4
1954 8
1955 8
1956 11
1957 5
1958 10
1959 13
1960 7
1961 14
1962 17
1963 6
1964 19
1965 18
1966 27
1967 21
1968 35
1969 28
1970 31
1971 22
1972 25
1973 25
1974 24
1975 42
1976 36
1977 30
1978 31
1979 40
1980 27
1981 44
1982 41
1983 36
1984 34
1985 43
1986 32
1987 32
1988 37
1989 38
1990 41
1991 46
1992 45
1993 56
1994 52
1995 49
1996 41
1997 37
1998 40
1999 39
2000 36
2001 40
2002 53
2003 47
2004 38
2005 57
2006 39
2007 55
2008 54
2009 47
2010 41
2011 46
2012 43
2013 47
2014 57
2015 61
2016 51
2017 74
2018 50
2019 50
2020 65
2021 48
2022 50
2023 35

Text availability

Article attribute

Article type

Publication date

Search Results

2,541 results

Results by year

Filters applied: . Clear all
Page 1
Pembrolizumab in Patients With Microsatellite Instability-High Advanced Endometrial Cancer: Results From the KEYNOTE-158 Study.
O'Malley DM, Bariani GM, Cassier PA, Marabelle A, Hansen AR, De Jesus Acosta A, Miller WH Jr, Safra T, Italiano A, Mileshkin L, Xu L, Jin F, Norwood K, Maio M. O'Malley DM, et al. Among authors: miller wh jr. J Clin Oncol. 2022 Mar 1;40(7):752-761. doi: 10.1200/JCO.21.01874. Epub 2022 Jan 6. J Clin Oncol. 2022. PMID: 34990208 Free PMC article. Clinical Trial.
Association of tumour mutational burden with outcomes in patients with advanced solid tumours treated with pembrolizumab: prospective biomarker analysis of the multicohort, open-label, phase 2 KEYNOTE-158 study.
Marabelle A, Fakih M, Lopez J, Shah M, Shapira-Frommer R, Nakagawa K, Chung HC, Kindler HL, Lopez-Martin JA, Miller WH Jr, Italiano A, Kao S, Piha-Paul SA, Delord JP, McWilliams RR, Fabrizio DA, Aurora-Garg D, Xu L, Jin F, Norwood K, Bang YJ. Marabelle A, et al. Among authors: miller wh jr. Lancet Oncol. 2020 Oct;21(10):1353-1365. doi: 10.1016/S1470-2045(20)30445-9. Epub 2020 Sep 10. Lancet Oncol. 2020. PMID: 32919526 Clinical Trial.
Reactive oxygen species: from health to disease.
Brieger K, Schiavone S, Miller FJ Jr, Krause KH. Brieger K, et al. Among authors: miller fj jr. Swiss Med Wkly. 2012 Aug 17;142:w13659. doi: 10.4414/smw.2012.13659. eCollection 2012. Swiss Med Wkly. 2012. PMID: 22903797 Free article. Review.
Older Adult Internet Use and eHealth Literacy.
Arcury TA, Sandberg JC, Melius KP, Quandt SA, Leng X, Latulipe C, Miller DP Jr, Smith DA, Bertoni AG. Arcury TA, et al. Among authors: miller dp jr. J Appl Gerontol. 2020 Feb;39(2):141-150. doi: 10.1177/0733464818807468. Epub 2018 Oct 24. J Appl Gerontol. 2020. PMID: 30353776 Free PMC article.
Moving towards personalized treatments of immune-related adverse events.
Esfahani K, Elkrief A, Calabrese C, Lapointe R, Hudson M, Routy B, Miller WH Jr, Calabrese L. Esfahani K, et al. Among authors: miller wh jr. Nat Rev Clin Oncol. 2020 Aug;17(8):504-515. doi: 10.1038/s41571-020-0352-8. Epub 2020 Apr 3. Nat Rev Clin Oncol. 2020. PMID: 32246128 Review.
Spatially mapping the immune landscape of melanoma using imaging mass cytometry.
Moldoveanu D, Ramsay L, Lajoie M, Anderson-Trocme L, Lingrand M, Berry D, Perus LJM, Wei Y, Moraes C, Alkallas R, Rajkumar S, Zuo D, Dankner M, Xu EH, Bertos NR, Najafabadi HS, Gravel S, Costantino S, Richer MJ, Lund AW, Del Rincon SV, Spatz A, Miller WH Jr, Jamal R, Lapointe R, Mes-Masson AM, Turcotte S, Petrecca K, Dumitra S, Meguerditchian AN, Richardson K, Tremblay F, Wang B, Chergui M, Guiot MC, Watters K, Stagg J, Quail DF, Mihalcioiu C, Meterissian S, Watson IR. Moldoveanu D, et al. Among authors: miller wh jr. Sci Immunol. 2022 Apr;7(70):eabi5072. doi: 10.1126/sciimmunol.abi5072. Epub 2022 Apr 1. Sci Immunol. 2022. PMID: 35363543
Avelumab plus Axitinib versus Sunitinib for Advanced Renal-Cell Carcinoma.
Motzer RJ, Penkov K, Haanen J, Rini B, Albiges L, Campbell MT, Venugopal B, Kollmannsberger C, Negrier S, Uemura M, Lee JL, Vasiliev A, Miller WH Jr, Gurney H, Schmidinger M, Larkin J, Atkins MB, Bedke J, Alekseev B, Wang J, Mariani M, Robbins PB, Chudnovsky A, Fowst C, Hariharan S, Huang B, di Pietro A, Choueiri TK. Motzer RJ, et al. Among authors: miller wh jr. N Engl J Med. 2019 Mar 21;380(12):1103-1115. doi: 10.1056/NEJMoa1816047. Epub 2019 Feb 16. N Engl J Med. 2019. PMID: 30779531 Free PMC article. Clinical Trial.
Talimogene Laherparepvec Improves Durable Response Rate in Patients With Advanced Melanoma.
Andtbacka RH, Kaufman HL, Collichio F, Amatruda T, Senzer N, Chesney J, Delman KA, Spitler LE, Puzanov I, Agarwala SS, Milhem M, Cranmer L, Curti B, Lewis K, Ross M, Guthrie T, Linette GP, Daniels GA, Harrington K, Middleton MR, Miller WH Jr, Zager JS, Ye Y, Yao B, Li A, Doleman S, VanderWalde A, Gansert J, Coffin RS. Andtbacka RH, et al. Among authors: miller wh jr. J Clin Oncol. 2015 Sep 1;33(25):2780-8. doi: 10.1200/JCO.2014.58.3377. Epub 2015 May 26. J Clin Oncol. 2015. PMID: 26014293 Clinical Trial.
Introduction.
Martin JG, Miller MJ Jr. Martin JG, et al. Among authors: miller mj jr. Tech Vasc Interv Radiol. 2017 Dec;20(4):229. doi: 10.1053/j.tvir.2017.10.011. Epub 2017 Nov 8. Tech Vasc Interv Radiol. 2017. PMID: 29224653 No abstract available.
2,541 results